Department of Anaesthesiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Department of Anesthesiology, Affiliated Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Front Public Health. 2023 Jan 4;10:1045141. doi: 10.3389/fpubh.2022.1045141. eCollection 2022.
Accumulating evidence has revealed that the aspartate aminotransferase to alanine aminotransferase (AST/ALT) ratio is a promising novel biomarker for insulin resistance (IR) and metabolic diseases. However, research on the association between the AST/ALT ratio and the incidence of diabetes progressing from prediabetes remains lacking. Herein, this study aimed to evaluate the relationship between the baseline AST/ALT ratio and risks of diabetes in patients with prediabetes.
This was a retrospective cohort study involving a total of 82,683 participants across 32 regions and 11 cities in China from 2010 to 2016. Data was obtained based on the DATADRYAD database from the health check screening program. Participants were stratified according to the interquartile range of the AST/ALT ratio (groups Q1 to Q4). The Cox proportional hazard model and smooth curve fitting were used to explore the relationship between the baseline AST/ALT ratio and the risk of diabetes in prediabetic patients. In addition, subgroup analysis was used to further validate the stability of the results.
The mean age of the selected participants was 49.9 ± 14.0 years, with 66.8% of them being male. During the follow-up period 1,273 participants (11.3%) developed diabetes progressing from prediabetes during the follow-up period. Participants who developed diabetes were older and were more likely to be male. The fully-adjusted Cox proportional hazard model revealed that the AST/ALT ratio was negatively associated with the risk of diabetes in prediabetic patients (HR = 0.40, 95% CI: 0.33 to 0.48, < 0.001). Higher AST/ALT ratio groups (Q4) also presented with a lower risk of progressing into diabetes (HR = 0.35, 95% CI: 0.29 to 0.43, < 0.001, respectively) compared with the lowest quintile group (Q1). Through subgroup analysis and interaction tests, it was found that the association stably existed in all subgroup variables, and there were a stronger interactive effects in people with age < 45 years, and TG ≤ 1.7 mmol/L in the association between AST/ALT ratio and diabetes incidences in patients with prediabetes ( for interaction < 0.05).
According to our study, a higher AST/ALT ratio is associated with a lower risk of progressing into diabetes from prediabetes. Regular monitoring of AST/ALT ratio dynamics and corresponding interventions can help prevent or slow prediabetes progression for diabetes.
越来越多的证据表明,天冬氨酸氨基转移酶与丙氨酸氨基转移酶(AST/ALT)比值是胰岛素抵抗(IR)和代谢性疾病的一种很有前途的新型生物标志物。然而,关于 AST/ALT 比值与从糖尿病前期进展而来的糖尿病发病率之间的关联的研究仍然缺乏。本研究旨在评估基线 AST/ALT 比值与糖尿病前期患者发生糖尿病的风险之间的关系。
这是一项回顾性队列研究,共纳入了 2010 年至 2016 年间来自中国 32 个地区和 11 个城市的 82683 名参与者。数据来源于 DATADRYAD 数据库中健康检查筛查计划的数据。参与者根据 AST/ALT 比值的四分位间距(Q1 到 Q4 组)进行分层。使用 Cox 比例风险模型和光滑曲线拟合来探讨基线 AST/ALT 比值与糖尿病前期患者发生糖尿病的风险之间的关系。此外,还进行了亚组分析以进一步验证结果的稳定性。
入选参与者的平均年龄为 49.9±14.0 岁,其中 66.8%为男性。在随访期间 1 内,有 1273 名参与者(11.3%)从糖尿病前期进展为糖尿病。发生糖尿病的参与者年龄较大,且更可能为男性。经过完全调整的 Cox 比例风险模型显示,AST/ALT 比值与糖尿病前期患者发生糖尿病的风险呈负相关(HR=0.40,95%CI:0.33 至 0.48,<0.001)。与最低五分位组(Q1)相比,AST/ALT 比值较高的组(Q4)进展为糖尿病的风险也较低(HR=0.35,95%CI:0.29 至 0.43,<0.001)。通过亚组分析和交互检验,发现该关联在所有亚组变量中均稳定存在,且在年龄<45 岁和 TG≤1.7mmol/L 的人群中,AST/ALT 比值与糖尿病前期患者的糖尿病发病率之间的交互作用更强(交互检验<0.05)。
根据本研究,较高的 AST/ALT 比值与从糖尿病前期进展为糖尿病的风险降低相关。定期监测 AST/ALT 比值的动态变化并进行相应的干预可能有助于预防或减缓糖尿病前期向糖尿病的进展。